       Document 2517
 DOCN  M94A2517
 TI    Epidemiological characteristics of HIV/AIDS prevalence in Japan.
 DT    9412
 AU    Kodama M; Kodama T; Kodama Res. Inst. Prev. Med., Nagoya, Japan.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):286 (abstract no. PC0065). Unique
       Identifier : AIDSLINE ICA10/94370058
 AB    OBJECTIVE: The present study investigated the epidemiological
       characteristics of HIV/AIDS prevalence in Japan so as to clarify the
       nature of this 20th Century pestilence now spreading in the world.
       METHODS: We made an access to the problem by attempting a comparison
       between Japan (a low-risk country) and USA (a high-risk country) by use
       of both new date and historical data derived from authentic source.
       RESULTS: Results obtained are as follows: 1) The increasing pattern of
       HIV/AIDS of Japan is still at the stage of geometric growth (an early
       stage), whereas that of USA is now approaching its saturation level (an
       advanced stage), as judged from the chronological transition of AIDS
       prevalence in the 2 countries. 2) The difference between the 2
       countries, as observed with the prevalence of HIV/AIDS in both average
       citizens and prostitutes, looks so remarkable that one cannot accept
       causal relationship between HIV infection and AIDS development without
       assuming the intervention of some discriminating mechanism in the
       genesis of AIDS. DISCUSSION AND CONCLUSIONS: Our findings are in support
       of the possibility that the differential risks for AIDS between USA and
       Japan could be related in its development to the participation of
       autoimmune mechanism, of which the expression is subject to change
       depending on the cultural background of a population.
 DE    Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/TRANSMISSION
       Comparative Study  Human  HIV Infections/*EPIDEMIOLOGY/TRANSMISSION
       Japan/EPIDEMIOLOGY  Prevalence  Risk Factors  United States/EPIDEMIOLOGY
       MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

